Shanghai Shyndec Pharmaceutical (600420.SH): Guoyao Rongsheng Vitamin B6 Injection increases specification and passes consistency evaluation.

Shanghai Shyndec Pharmaceutical (600420.SH) announced that its wholly-owned subsidiary, Guoyao Group Rongsheng Pharmaceutical Co., Ltd. (referred to as Guoyao Rongsheng), recently received the Drug Supplementary Application Approval Notice issued by the National Medical Products Administration. The notice approved the increase in specifications for vitamin B6 injection and passed the generic drug quality and efficacy consistency evaluation, and issued a drug approval number. The increase in specifications for Guoyao Rongsheng vitamin B6 injection and passing the consistency evaluation will be beneficial for the future market expansion and sales of the product. The above-mentioned matters will not have a significant impact on the company's current operating performance.